Contineum Therapeutics Reports Second-Quarter 2026 Financial Results; Affirms Key Clinical Development Milestones businesswire.com July 30, 2026 at 3:05 PM ET CTNM The article reports on Contineum Therapeutics' second-quarter 2026 financial results and affirms key clinical development milestones. No specific positive or negative performance indicators are highlighted.